Peer Review History

Original SubmissionApril 12, 2020
Decision Letter - Daniele Marinazzo, Editor

Dear Mr. Butenko,

Thank you very much for submitting your manuscript "OSS-DBS: Open-Source Simulation platform for Deep Brain Stimulation with automated volume conductor model design and advanced field modeling." for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please make sure that the code and material necessary to reproduce and extend the results is correctly accessible on a third party repository (this will be checked prior to acceptance).

Also as you anticipated, make sure that you address the paper on a similar topic recently published which you brought our attention to.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. 

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Daniele Marinazzo

Deputy Editor

PLOS Computational Biology

Daniele Marinazzo

Deputy Editor

PLOS Computational Biology

***********************

A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact ploscompbiol@plos.org immediately:

[LINK]

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In their manuscript entitled “OSS-DBS: Open-Source Simulation platform for Deep Brain Stimulation with automated volume conductor model design and advanced field modeling.” – Butenko et al. propose a novel open source toolbox to estimate electrical models of deep brain stimulation electrodes surgically implanted in rodents and humans.

Already, the van Rienen group is one of the leading groups working on precise bioelectrical models and the group has shown similar outstanding work in the past. Making their pipeline available in form of an easy-to-install software is highly relevant to the field of DBS since set up of commercial tools requires costly & time-consuming infrastructure and is not feasible in every lab studying the effects of DBS.

Hence, I do believe this will be a major addition to the field and will more broadly enable studying the complex effects of DBS onto the brain. Currently, there also is no openly available alternative that is capable of what OSS-DBS is able to do.

The manuscript is very well written, methods are accurate & figures are appropriate. I have only minor things to add and one suggestion that could be amended if possible without major additional work.

Namely, one open source alternative that is broadly used in the more clinically oriented field (Lead-DBS, www.lead-dbs.org, also cited by the authors) comprises of a much more limited FEM-based VTA model. Thus, a direct exemplary comparison between results from Lead-DBS (say in a single patient) and OSS-DBS could be interesting to the medical community. Are results similar? If they are different, what reasons may apply? Which settings in the larger parameter space of OSS-DBS would lead to similar solutions as in Lead-DBS?

Again, authors should see this as a suggestion only.

Minor:

- Are the insulating parts of the electrodes explicitly modeled? I do think those would have an effect on the shape of the stimulation volume.

- I think dystonias (plural) in the introduction is a bit uncommon (singular dystonia would be more appropriate here).

- St. Jude Medical was bought by Abbott, so maybe specifying electrode types with the novel name is more appropriate.

Reviewer #2: In this manuscript, the authors introduced a python-based platform (OSS-DBS) to control workflow for simulating deep brain stimulation, which provides an efficient and more realistic volume conducting model with the easy-to-use automated user interface.

The proposed workflow utilized open-source software and libraries to facilitate accessibility and reproducibility of computational simulation on both clinical and research applications of DBS.

The Authors also performed the benchmarks the accuracy of their proposing model by comparing with commercial software (COMSOL). Using this result, they demonstrated the platform shows high efficiency and accuracy in estimating the volume of tissue activation (VTA) for both human and rat brain by utilizing their mash adaptation refinement algorithm.

However, the lack of presenting any example regarding the user-interface is one major downside of this manuscript. So this reviewer would like to recommend to the authors to provide usage examples (with some screenshot of the user interface) on supplementary so that readers can get a better idea of how the platform can benefit their research. This aspect was not able to evaluate in terms of easy to use or rapid setup capability which authors claimed, because all link that authors provide was not accessible for the reviewers.

In addition to this, I have following comments and questions,

1. In the abstract and introduction, the authors mentioned that this platform ‘is suitable for a clinical study.’ Still, since this software could be classified as ‘clinical decision support’ software for deep brain stimulation surgery, authors may need to check about the regulation on this category of the software if there is no issue to describe as ‘suitable for clinical use.’

2. While the authors state that this platform provides a highly automated solution, but since there is no real demonstration of platform operation, it is not clear the level of automation that this platform is providing. For example, I am wondering interacting with other GUI software such as Paraview also fully automated and how much time could take on a regular operation task (for example, for the benchmark example) if the user has all parameters in hands.

3. The authors state that the platform offers to the user to choose an electrode geometry from the predefined collection. Does this customizable? If so, could the experimentally measured impedance spectrometer result also be used as input for estimating electrode-tissue interface?

4. While the authors mentioned that there are some limitations on performance, it is not clear what is the minimal requirement to use the platform for the demonstrated simulations (especially for the docker image). It would be helpful to the reader If the authors can provide the computing time to reproduce the same result with a sample dataset with validated hardware specs (which the hardware environment that authors operate the simulation), as supplementary.

5. Regarding the parallel computing in the frequency domain, Have the authors evaluate how much the computing time improved (by %) after parallelization compared to the serial processing? If so, do authors have any recommendations on this setting?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: No: All links provided by the authors were not working.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/ploscompbiol/s/submission-guidelines#loc-materials-and-methods

Revision 1

Attachments
Attachment
Submitted filename: Butenko_Answers_and_corrections.pdf
Decision Letter - Daniele Marinazzo, Editor

Dear Mr. Butenko,

We are pleased to inform you that your manuscript 'OSS-DBS: Open-Source Simulation Platform for Deep Brain Stimulation with a comprehensive automated modeling' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Daniele Marinazzo

Deputy Editor

PLOS Computational Biology

Daniele Marinazzo

Deputy Editor

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Authors have successfully addressed all concerns raised.

I would like to congratulate them for their seminal work to publish a much needed open source software for modeling complex DBS effects.

Reviewer #2: The authors have addressed all of my comments regarding the original manuscript and revised it sufficiently. Therefore, I don't have additional comments on this revised version, and I think the current manuscript has enough quality for publication in PLOS Computational Biology.

Regarding the authors' question related to the GitHub repository in the general comments, I was not able to access the linked repository with the message that the repository did not exist at the time I have been reviewing the original manuscript. This time, the issues resolved so I can access the link that the authors provided.

It seems the issue occurred because the access had tried before the authors first commit (May-11th). So, I think it would not happen for the future publication if the commit made before the review process.

Best regards

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Daniele Marinazzo, Editor

PCOMPBIOL-D-20-00599R1

OSS-DBS: Open-Source Simulation Platform for Deep Brain Stimulation with a comprehensive automated modeling

Dear Dr Butenko,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Matt Lyles

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .